ARTICLE | Company News
MiniVax, University of Rochester deal
January 20, 2014 8:00 AM UTC
The university granted MiniVax an exclusive option to license a preclinical mAb to treat Pneumocystis pneumonia. MiniVax will conduct additional preclinical testing and is responsible for beginning cl...